Melilotus-Homaccord® N

Melilotus-Homaccord® N



Injection solution Composition:

Drops: 100 g cont.: Melilotus officinalis D1, Melilotus officinalis D4, Melilotus officinalis D10, Melilotus officinalis D30, Melilotus officinalis D200 0.2 g each; Crataegus Ø 60 g; Crataegus D10, Crataegus D30, Crataegus D200 0.8 g each. Contains 45 vol.-% alcohol.

Injection solution: 1.1 ml cont.: Melilotus officinalis D2, Melilotus officinalis D4,  Melilotus officinalis D10, Melilotus officinalis D30, Melilotus officinalis D200 2.2 µl each; Crataegus D2, Crataegus D10, Crataegus D30, Crataegus D200 8.8 µl each.


Plethora; pre-apoplectic conditions; hypertension.


Drops: In general, 10 drops 3 times daily; in acute disorders, initially 10 drops every 15 minutes, over a period lasting up to two hours. Long-term application of the  preparation (over several months or longer) must be supervised by a therapist.

Injection solution: In acute disorders daily, otherwise 3-1 times weekly 1 ampoule i.m., s.c., i.d.

Package sizes:

Drops: Drop bottles containing 30 and 100 ml.

Injection solution: Packs containing 5, 10, 50 and 100 ampoules of 1.1 ml.

Pharmacological and clinical notes

Melilotus officinalis (melilot)

Congestion of the blood in the head and cephalalgia, improved by blowing the nose; plethora, possibly with pre-apoplectic conditions (high blood pressure).

Crataegus (whitethorn)

Senile heart, regulation of coronary disorders of the circulation, pre-insufficiency, arteriosclerotic and constitutional high blood-pressure, hypertonic heart; general sedative.

Based on the individual homoeopathic constituents of Melilotus-Homaccord, therapeutic possibilities result for the treatment of hypertonia, plethora; congestion of the blood in the head with cephalalgia and dizziness (Vertigoheel as auxiliary remedy), improvement through blowing the nose; pre-apoplectic conditions, oppression of the heart (in alternation with Cardiacum-Heel and Aurumheel N drops), coronary disorders of the circulation and anginal disorders (alternation with Glonoin-Homaccord).

The dosage is adjusted according to the disease, the symptoms and the stage of the illness: 10 drops 3-4 times daily; for acute disorders, as well as when there is danger of an apoplectic attack, massive initial-dose therapy: 10 drops every 15 minutes (in addition to Papaver-Injeel, Belladonna-Injeel S, etc.). In acute disorders, 1 ampoule daily, otherwise 1 ampoule 1-3 times weekly, i.m., s.c., i.d., i.v.